Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Long-COVID (LC) is characterised by persistent symptoms for at least 3 months after acute infection. A dysregulation of the immune system and a persistent hyperinflammatory state may cause LC. LC patients present differences in activation and exhaustion states of innate and adaptive compartments. Different T CD4 cell subsets can be identified by differential expression of chemokine receptors (CCR). However, changes in T cells with expression of CCRs such as CCR6 and CXCR3 and their relationship with CD8 T cells remains unexplored in LC. Here, we performed unsupervised analysis and found CCR6 CD4 subpopulations enriched in COVID-19 convalescent individuals upon activation with SARS-CoV-2 peptides. SARS-CoV-2 specific CCR6 CD4 are decreased in LC patients, whereas CXCR3 CCR6 and CCR4 CCR6 CD4 T cells are increased. LC patients showed lower IFN-γ-secreting CD8 T cells after stimulation with SARS-CoV-2 Spike protein. This work underscores the role of CCR6 in the pathophysiology of LC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clim.2024.110267 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hepatitis C virus modified E2-mRNA-LNP candidate vaccine promotes helper CXCR5T cells.
J Virol
September 2025
Department of Internal Medicine, Saint Louis University, St. Louis, Missouri, USA.
T cells play an important role in initiating antibody responses by instructive signals of cell-cell contacts and secretion of soluble cytokines as mediators. We investigated the role of the modified soluble E2 (sE2) antigen from hepatitis C virus (HCV) on healthy human peripheral blood mononuclear cell (PBMC)-derived immune cells or immunized mouse cells to understand the mechanisms of immune regulation by the candidate vaccine antigen. HCV E2 and E2 displayed a role in inducing type 17 T-helper cell (Th17) phenotype, as indicated by interleukin-17 (IL-17) expression and signal transducer and activator of transcription 3 (Stat3) phosphorylation.
View Article and Find Full Text PDFBackground: T cells are contributors to atherosclerosis pathogenesis. Granulocyte-macrophage-colony-stimulating factor (GM-CSF)-producing T helper (ThGM) cells, a specialized helper T cell subset that highly expresses GM-CSF but lacks other helper T cell markers, could exacerbate atherosclerosis development. Calycosin has been reported to suppress atherosclerosis progression.
View Article and Find Full Text PDFAberrant T-cell phenotypes in a cohort of patients with post-treatment Lyme disease.
Front Immunol
July 2025
Lyme Disease Research Center, Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Post-treatment Lyme Disease (PTLD) is a poorly understood complication of infection with significant patient morbidity. Characterized by fatigue, generalized myalgias, and cognitive impairment, PTLD symptomatology closely resembles long COVID and other post-acute infection syndromes. While prior studies suggest immune dysregulation as a factor in PTLD pathogenesis, the mechanisms underlying its heterogeneous presentation and severity remain unclear.
View Article and Find Full Text PDFCorrelation between T cell immunity and the duration of EGFR-TKI resistance acquisition in patients harboring EGFR mutations.
Cancer Immunol Immunother
July 2025
Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center,, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1298, Japan.
Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) control lung cancer in patients with EGFR mutations, but resistance develops over time. Patients with high levels of genetic mutations rapidly acquire EGFR-TKI resistance. T cell immunity recognizes gene mutation products as neoantigens that effectively suppress mutation levels by eliminating clones with more mutations; this process is known as cancer immune editing.
View Article and Find Full Text PDFMulti-GWAS analysis illuminates druggable targets for rheumatoid arthritis.
Postgrad Med J
July 2025
Department of Orthopaedics, The First Affiliated Hospital of Soochow University, 899 Pinghai Road, Gusu District, Suzhou, Jiangsu Province 215000, China.
Objective: Despite the treatment choices for rheumatoid arthritis (RA) increasing, there remain unmet preventive and therapeutic needs for RA. This study aimed to identify effective drug target genes to reduce RA risk through the multi-genome-wide association studies analysis.
Methods: A Mendelian randomization (MR) analysis was conducted to investigate the causal effects of druggable expression quantitative trait loci (eQTLs) in the blood on RA.